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Background: Cancer is often described as the ‘number one’ health fear, but little is known about whether this
affects quality of life by translating into high levels of worry or distress in everyday life, or which population groups
are most affected. This study examined the prevalence of three components of cancer fear in a large community
sample in the UK and explored associations with demographic characteristics.
Methods: Questions on cancer fear were included in a survey mailed to a community sample of adults (n = 13,351;
55–64 years). Three items from a standard measure of cancer fear assessed: i) whether cancer was feared more than
other diseases, ii) whether thinking about cancer caused discomfort, and iii) whether cancer worry was experienced
frequently. Gender, marital status, education, and ethnicity were assessed with simple questions. Anxiety was
assessed with the brief STAI and a standard measure of self-rated health was included.
Results: Questionnaire return rate was 60% (7,971/13,351). The majority of respondents agreed or strongly agreed
that they feared cancer more than other diseases (59%), and felt uncomfortable thinking about it (52%), and a
quarter (25%) worried a lot about cancer. All items were significantly inter-correlated (r = .35 to .42, p’s < .001), and
correlated with general anxiety (r = .16 to .28, p’s < .001) and self-rated health (r = −.07 to -.16, p’s < .001). In multivariable
analyses including anxiety and general health, all cancer fear indicators were significantly higher in women (ORs between
1.15 and 1.48), respondents with lower education (ORs between 1.40 and 1.66), and those with higher general anxiety
(ORs between 1.50 and 2.11). Ethnic minority respondents (n = 285; 4.4%) reported more worry (OR: 1.85).
Conclusions: More than half of this older adult sample in the UK had cancer as greatest health fear and this was
associated with feeling uncomfortable thinking about it and worrying more about it. Women and respondents with less
education or from ethnic minority backgrounds were disproportionately affected by cancer fear. General anxiety and poor
health were associated with cancer fear but did not explain the demographic differences.
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Cancer occupies an almost unique position among dis-
eases in terms of the fear it engenders. The word ‘cancer’
was once considered unacceptable in the public sphere,
and even today, euphemisms such as ‘the Big C’ are
common. In the 1950s, the British Empire Cancer Cam-
paign concluded that education about early symptoms of
cancer in Britain would create mass panic [1]; and simi-
lar issues have been raised in connection with campaigns
to promote self-examination for early signs of testicular
cancer in the UK [2]. Polls in the US and Europe find* Correspondence: j.wardle@ucl.ac.uk
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unless otherwise stated.that at least half the population say they fear cancer
more than any other disease [3-5], and around a third to
a fifth say they fear cancer more than other potential catas-
trophes, such as violent crime, debt, and losing a job [3,6].
Fear is an unpleasant emotion and the pervasiveness
of cancer fear in the population may have implications
for quality of life. In addition, cancer fear has been
shown to be associated with screening uptake and pres-
entation of suspicious symptoms, although both motivat-
ing and deterrent associations have been found (for an
overview, see [7,8]). In the light of the frequency of pub-
lic statements about cancer fear, it is clearly a societally
important matter. Most research to date has examinedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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have focused on cancer fear itself are mostly qualitative
(e.g. [11]) or done in undergraduate student samples for
whom the threat of cancer is less relevant due to their
young age [12,13]. A better understanding of the nature
of cancer fear may help identify those who suffer from
maladaptive and undue fears, and help explain why the
behavioural responses seem to vary.
Fear as an emotion has a complex architecture, with
cognitive, physiological and affective components that
may be only loosely interconnected. These components
are often not distinguished in the cancer context, and
terms such as ‘cancer fear’ and ‘cancer worry’ are some-
times used synonymously (for example, see [7,8,14]). A
failure to distinguish between different fear components
may have contributed to the apparent inconsistencies in
the behavioural effects of fear. For example, appraising
cancer as uniquely frightening may lead to avoidance of
the fear stimulus, while worry may encourage behaviours
that will result in reassurance. Appraising cancer as
uniquely frightening cannot therefore be assumed to
translate into high levels of worry or avoidance [13] or
show the same behavioural outcomes. To date, no stud-
ies have examined the associations between the appraisal
of cancer as frightening, discomfort when thinking about
cancer, and worry about cancer, nor investigated whether
demographic and psychosocial correlates are consistent
across the different components of cancer fear. Large
datasets that include different indicators of cancer fear
are needed to examine the interconnections between
different fear components.
Some previous studies have explored associations be-
tween different aspects of fear, although these were mainly
conducted in the context of specific cancer screening pro-
grammes. Consedine et al. [15] explored three aspects of
fear: trait anxiety, prostate cancer worry, and screening fear,
in a sample of older men in the US. All three were associ-
ated with lower income and education, and prostate cancer
worry and screening fear, but not trait anxiety, was higher
in Black men. Another study from the US found strong
associations between cancer worry and cancer-related
discomfort among women with and without a family
history of breast cancer, but only moderate associa-
tions between cancer worry and trait anxiety [13].
Another examined the contributions of cancer worry
and cancer-related distress to breast screening uptake
in women at an increased familial risk, but did not
report the associations between the different fear com-
ponents [16]. No large studies on inter-relationships
between the components of cancer fear have been
conducted outside the US.
Little is known about the demographic correlates of
individual fear components. Polls in the US and Europe
that show cancer to be uniquely frightening have notexplored whether certain subgroups are more likely to
endorse this view, although a French survey noted that
more women than men viewed cancer as their ‘number
one’ fear [4]. The 2003 Health Information National
Trends Survey (HINTS; [17]) and the Pittsburgh Lung
Screening study [18] both showed higher cancer worry
in women. Lower socioeconomic status (SES) was as-
sociated with cancer worry in both these studies, and
in the UK Flexible Sigmoidoscopy Trial [19]. Ethnic
minority status has been linked with higher cancer
worry in studies in the US and UK [15,20-22], although
the association has differed by type of cancer and spe-
cific ethnic background [17,23]. The reason that so lit-
tle is known about the correlates of general cancer fear
is partly that much previous work measured single
components of cancer fear and focussed specifically on
associations with screening uptake, without exploring
the population distribution of fear (e.g. [15,16,21]).
An important potential confounder in studies of
demographic variation in cancer fear is general anxiety.
Anxiety tends to be higher among women and more
socially disadvantaged groups [24,25], so might explain
sex or education differences in cancer fear. Results
have been more varied in relation to ethnicity. African
American men showed lower trait anxiety than White
Americans despite higher prostate cancer worry in one
study [15]. In the HINTS results, controlling for psy-
chological distress reduced both gender and ethnic
differences in cancer worry, although multiple other be-
havioural factors were also included as control variables,
making it difficult to identify whether psychological distress
was the key confounder. High trait anxiety has also been
shown to increase the effect of media breast cancer mes-
sages on breast cancer fear [26].
The present study aimed to examine associations be-
tween three indicators of cancer fear that represent dif-
ferent components (having cancer as greatest health
fear, discomfort thinking about cancer, and cancer
worry) and associations between all three and general
anxiety. It also explored the demographic correlates of
the three components and examined whether effects
were explained by differences in general anxiety and
self-rated health. There is no prima facie reason to be-
lieve that the architecture of cancer fear would be
different across cultures, but the socio-demographic
correlates may vary between countries because of dif-
ferences in healthcare provision, public knowledge of
cancer, or beliefs about cancer prevention. Few previ-
ous studies of cancer fear have been conducted in the
UK, a country that has a well-organised health care
system, but also a tradition of the ‘stiff upper lip’, and a
history of reluctance among health professionals to
provide much public information about cancer for fear
of scaring the public.
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Design and procedure
Data for this secondary data analysis come from the
baseline questionnaires mailed between 1996 and 1999
to all adults aged 55–64 years (i.e. born between 1932
and 1943) registered in 506 General Practices taking part
in the UK Flexible Sigmoidoscopy (FS) Trial. This was a
multi-centre, randomised controlled trial to evaluate the
efficacy of FS screening on colorectal cancer incidence
and mortality [27,28]. Cancer worry, general anxiety, and
attitudes and beliefs about cancer and screening were
also assessed in a subset of Practices [27]. Potential par-
ticipants were identified by Health Authorities, and GPs
were asked to exclude any patients who were ineligible
(a history of colorectal cancer, adenomas or inflamma-
tory bowel disease, severe disease or a life expectancy of
less than five years, endoscopic colorectal examination
within the past three years). This excluded 7,602 partici-
pants (2%; [29]). The remaining participants (n = 368,142)
were sent an information letter about the study together
with the baseline questionnaire. In a subsample of Prac-
tices, with a total of 13,351 eligible adults, the baseline
questionnaire included questions on cancer fear, as well as
a range of demographic, health, and psychosocial measures.
The UK FS Trial was conducted in accordance with the
Declaration of Helsinki and approval was obtained from
the local research ethics committee for all participating
centres.
Measures
Cancer fear was assessed with three items adapted from
Berrenberg’s Cancer Attitude Inventory [30]: i) ‘Of all
the diseases there are, I am most afraid of cancer’ (‘cancer
as greatest health fear’), ii) ‘It makes me uncomfortable to
think about cancer’ (‘discomfort thinking of cancer’), and
iii) ‘I worry a lot about cancer’ (‘cancer worry’). The Cancer
Attitude Inventory is a 41-item measure of attitudes to-
wards cancer that encompasses a range of domains includ-
ing cancer stigma, economic hardship, and potential for
positive growth. The three items used in this study were
chosen as potentially representing different aspects of can-
cer fear. All items used a 5-point Likert response scale from
‘strongly disagree’ to ‘strongly agree’. For the chi-square
analyses and the multivariable logistic regression analyses,
responses of ‘agree’ or ‘strongly agree’ were combined to
define the higher fear response (i.e. those who agreed with
the fear statement).
General anxiety was assessed with the 6-item State
version of the Spielberger State Trait Anxiety Inven-
tory [31]. Total scores ranged from 6 to 24, and were
dichotomised for the chi-square and multivariable lo-
gistic regression analyses. For ease of interpretation of
the results, groups scoring below or above the group
average (<11 vs. ≥11) were created. Self-rated generalhealth was included as a control variable and assessed
with the question: ‘Would you say that for someone of
your age your own health in general is’: ‘poor’, ‘fair’,
‘good’, ‘excellent’ [32]. For binary analyses responses
were dichotomised into ‘poor or fair’ and ‘good or
excellent’.
Demographic data came either from the GP database
(age and sex) or were assessed in the questionnaire
(ethnicity, marital status, education). Age was dichoto-
mised into ‘younger than 60’ and ‘60 years or older’, to
aid interpretation of the results. Ethnicity was reported
using 5 categories (‘White’, ‘Black’, ‘Asian’, ‘other’, and
‘prefer not to say’), but for these analyses, ‘Black’ (n = 79),
‘Asian’ (n = 166) and ‘other’ (n = 40) were combined be-
cause the numbers in each individual group were small,
and ‘prefer not to say’ was coded as missing. Marital status
was reported in 5 categories (‘married/living as married’, ‘di-
vorced’, ‘separated’, ‘widowed’, ‘single’), and dichotomised
into ‘married or cohabiting’ and ‘not married or cohabiting’.
Education was assessed with a single item (‘do you have
any educational qualifications, e.g. School Certificate, GCE
O’Levels, etc.’) with a ‘yes’ and ‘no’ answer. These are exam-
inations taken at age 16 in the UK. In the cohort born be-
tween 1932 and 1943 in the UK, continuation in education
would have been dependent on passing these examinations.
Education has been shown to be a good measure of SES in
older adults [33].Statistical analysis
To examine associations between the three fear indica-
tors, general anxiety, and general health, we calculated
Spearman’s correlations using the values before dichot-
omisation. To explore whether having cancer as the
greatest health fear translated into high levels of worry
or discomfort, we explored associations between the
three fear indicators using chi-square tests for the
dichotomised items. Univariate chi-square analyses
were then used to examine demographic correlates of
each cancer fear indicator using dichotomised values.
To explore the consistency in the demographic corre-
lates of the three fear components while controlling for
differences in general anxiety and self-rated general health,
two sets of multivariable logistic regression analyses using
the dichotomised items were carried out: one that only
included the demographic variables as predictors of each
separate fear indicator (Model 1), and one that controlled
for anxiety and self-rated health (Model 2). Because of the
multiple comparisons, a Bonferroni correction was applied
to control the family-wise error rate for an overall alpha
level of .05, and thus a p-value of .001 was used to indicate
statistical significance. The sample for analysis consisted of
respondents with complete information on all study vari-
ables. SPSS version 20.0 was used for all analyses.
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The questionnaire was mailed to 13,351 adults in the eli-
gible age range in participating General Practices. The
return rate was 59.7% (n = 7,971), of which 6,527 (82%
of responses) had complete data on all variables. There
were slightly more women (53%) than men (47%). More
than half the respondents had no educational qualifica-
tions (63%), and the majority were of White ethnic origin
(96%) and married or cohabiting (75%). The mean STAI
score was 10.6, which is comparable to other community-
based studies of older adults [34,35]. Most respondents
(70%) rated their health as good or excellent.
Over half the respondents agreed (or strongly agreed)
that: ‘Of all the diseases there are, I am most afraid of
cancer’ (59%), and almost as many (52%) agreed that: ‘It
makes me uncomfortable to think about cancer’. A smaller
proportion (25%) agreed with: ‘I worry a lot about cancer’.
Characteristics of the sample are presented in Table 1.
Associations between the cancer fear indicators
Spearman’s correlations showed that cancer as the great-
est health fear was significantly correlated with both dis-
comfort thinking about cancer (r = .37, p < .001) andTable 1 Associations with demographic factors, health status
Characteristic (n) Whole sample Cancer as greates
% % Signif
Whole sample (6,527) 100 58.7 -
Gender
Male (3,043) 46.6 54.7 χ2 = 37
Female (3,484) 53.4 62.2 p < .00
Age
< 60 years (3,300) 50.6 59.2 χ2 = 0.
≥ 60 years (3,227) 49.4 58.1 p = .36
Educational qualifications
Yes (2,412) 37.0 50.7 χ2 = 10
No (4,115) 63.0 63.4 p < .00
Ethnicity
White (6,242) 95.6 58.5 χ2 = 1.
Not White (285) 4.4 62.1 p = .23
Marital status
Married or cohabiting (4,877) 74.7 58.7 χ2 = 0.
Not married or cohabiting (1,650) 25.3 58.5 p = .91
General health
Excellent/good (4,591) 70.3 57.3 χ2 = 11
Fair/poor (1,936) 29.7 61.8 p < .01
Anxiety
Low (3,624) 55.5 53.8 χ2 = 81
High (2,903) 44.4 64.8 p < .00
*Percentages for the cancer fear indicators represent those with higher fear, i.e. thocancer worry (r = .42, p < .001; see Table 2). Chi-square
tests showed that of those who had cancer as the great-
est health fear, 65% also said that they felt uncomfortable
thinking about cancer, compared with 34% of those who
did not have cancer as the greatest health fear (χ2 (1) =
630.8, p < .001). Similarly, 37% of those who had cancer
as greatest health fear said they also worried about
cancer a lot compared with 8% of those who did not
(χ2 (1) = 696.7, p < .001). These results suggest that hav-
ing cancer as greatest health fear translates to some ex-
tent into high levels of worry and discomfort thinking
about the disease.
Demographic predictors of cancer fear
Univariate chi-square analyses were used to explore the
associations between demographic variables and the
three cancer fear indicators. The results are presented in
Table 1 and show that significantly more women than
men had cancer as greatest health fear (62% vs. 55%), felt
uncomfortable thinking about cancer (55% vs. 50%), and
worried a lot about cancer (29% vs. 20%). Respondents
without educational qualifications (vs. with qualifica-
tions) were also more likely to have cancer as greatest, and anxiety for each cancer fear indicator*
t health fear Discomfort thinking about cancer Cancer worry
icance % Significance % Significance
52.3 - 24.9 -
.88 49.6 χ2 = 16.84 20.4 χ2 = 60.66
1 54.7 p < .001 28.8 p < .001
83 52.8 χ2 = 0.48 24.8 χ2 = 0.001
51.9 p = .49 24.9 p = .97
0.99 46.1 χ2 = 58.81 20.2 χ2 = 43.97
1 56.0 p < .001 27.6 p < .001
46 52.1 χ2 = 3.24 24.3 χ2 = 24.24
57.5 p = .07 37.2 p < .001
01 51.5 χ2 = 5.32 23.8 χ2 = 10.73
54.8 p < .05 27.9 p < .01
.37 49.6 χ2 = 46.56 21.3 χ2 = 102.64
58.8 p < .001 33.2 p < .001
.05 45.0 χ2 = 176.87 17.4 χ2 = 244.14
1 61.5 p < .001 34.2 p < .001
se who responded ‘agree’ or ‘strongly agree’.
Table 2 Spearman’s correlations between the three cancer
fear indicators, anxiety and general health (N = 6,527)
Cancer as greatest
health fear
Discomfort
thinking
about cancer
Cancer
worry
General
anxiety
Cancer
discomfort
.37
Cancer worry .42 .35
General anxiety .16 .23 .28
General health -.07 -.11 -.16 -.29
All presented correlations were significant at p < .001.
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about it (56% vs. 46%), and worry a lot about cancer
(28% vs. 20%). Respondents from ethnic minority back-
grounds were more likely to worry about cancer (37%
vs. 24% in the White group), but ethnic differences inTable 3 Adjusted Odds Ratios (OR) and 95% Confidence Inter
Cancer as greatest health fear Dis
Model 1 Model 2 Mo
OR (95% CI) OR (95% CI) OR
Gender
Male REF REF REF
Female 1.34* (1.23-1.50) 1.31* (1.18-1.45) 1.21
Age
< 60 years REF REF REF
≥ 60 years 0.92 (0.83-1.01) 0.93 (0.84-1.02) 0.94
Educational qualifications
Yes REF REF REF
No 1.70* (1.53-1.88) 1.66* (1.49-1.84) 1.49
Ethnicity
White REF REF REF
Not White 1.30 (1.01-1.66) 1.24 (0.96-1.59) 1.35
Marital status
Married or cohabiting REF REF REF
Not married or cohabiting 0.95 (0.84-1.06) 0.91 (0.81-1.03) 1.11
General health
Excellent/good - REF -
Fair/poor 1.05 (0.94-1.18)
Anxiety
Low - REF -
High 1.50* (1.35-1.66)
Nagelkerke R2 .029 .042 .017
χ2 (5) = 142.6,
p < .001
χ2 (7) = 206.3,
p < .001
χ2 (
p <
*p < .001.
Abbreviations: REF reference category, OR odds ratio, CI confidence interval.
Adjusted ORs and 95% CIs for the demographic predictors only (Model 1), and the
(Model 2), for each cancer fear indicator.discomfort thinking about cancer or having cancer as
the greatest health fear were not significant. Age and
marital status were not associated with any cancer fear
indicator.
We used multiple logistic regression in an analysis
that included all demographic characteristics in a sin-
gle model (Table 3, Model 1). The associations between
the demographic variables and the cancer fear indica-
tors were very similar to the results of the univariate
analyses, with significant effects of gender and educa-
tion for all three fear indicators, and of ethnicity for
cancer worry. Associations with marital status and
age were not significant. All demographic predictors
combined explained 2.9% of variance in having cancer
as greatest health fear, 1.7% of the variance in discom-
fort thinking about cancer, and 3.1% of variance in can-
cer worry.vals (CI)
comfort thinking about cancer Cancer worry
del 1 Model 2 Model 1 Model 2
(95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
REF REF REF
* (1.09-1.33) 1.15 (1.04-1.27) 1.56* (1.39-1.75) 1.48* (1.33-1.67)
REF REF REF
(0.85-1.03) 0.95 (0.86-1.05) 0.97 (0.86-1.08) 0.99 (0.88-1.11)
REF REF REF
* (1.35-1.65) 1.43* (1.29-1.58) 1.52* (1.34-1.71) 1.40* (1.24-1.59)
REF REF REF
(1.06-1.72) 1.24 (0.97-1.59) 2.06* (1.60-2.65) 1.85* (1.43-2.39)
REF REF REF
(0.99-1.24) 1.05 (0.93-1.17) 1.17 (1.03-1.33) 1.08 (0.95-1.23)
REF - REF
1.22* (1.09-1.36) 1.50* (1.33-1.70)
REF - REF
1.82* (1.64-2.02) 2.11* (1.90-2.42)
.050 .031 .084
5) = 84.3,
.001
χ2 (7) = 250.9,
p < .001
χ2 (5) = 138.4,
p < .001
χ2 (7) = 382.4,
p < .001
demographic predictors combined with general anxiety and general health
Vrinten et al. BMC Cancer 2014, 14:597 Page 6 of 9
http://www.biomedcentral.com/1471-2407/14/597Anxiety and general health as predictors of cancer fear
We then explored whether sociodemographic differences
in the three cancer fear indicators were partly driven by
differences in general anxiety or health. State anxiety
was significantly correlated with all three indicators of can-
cer fear (r = .16 to .28, all p < .001; see Table 2). Chi-square
analyses showed that respondents with high versus low
general anxiety were more likely to have cancer as the
greatest health fear (65% vs. 54%), feel uncomfortable think-
ing about cancer (62% vs. 45%) and worry a lot about can-
cer (34% vs. 17%; see Table 1).
Self-rated health was modestly negatively correlated
with the three indicators of cancer fear (r = −.07 to -.16,
all p < .001). Respondents with fair/poor versus good/ex-
cellent health were more likely to worry about cancer
(33% vs. 21%) and feel uncomfortable thinking about
cancer (59% vs. 50%), but there were no health differ-
ences in having cancer as the greatest health fear.
The second set of regression models (Table 3, Model
2) included the variables in Model 1 plus general health
and general anxiety. This made no material difference to
the effect sizes associated with gender or SES, and worry
about cancer was still higher in ethnic minority respon-
dents. In the fully-adjusted model, general anxiety was
an independent predictor of all three fear indicators,
while health status was associated with cancer worry and
discomfort thinking about cancer. The addition of gen-
eral health and anxiety to the model increased the pro-
portion of variance explained by the model to 4.2% for
having cancer as greatest health fear, 5.0% for discomfort
when thinking about cancer, and 8.4% for cancer worry.Discussion
More than half this large, community-based sample of
55–64 year-olds in the UK had cancer as greatest health
fear and felt uncomfortable thinking about it, and a
quarter said they worried ‘a lot’ about cancer. The three
indicators were moderately inter-correlated, suggesting
some commonality between the three facets of cancer
fear. This was supported by finding similar demographic
correlates, with all three fear indicators being higher in
women and respondents with lower levels of education,
and none being associated with age or marital status.
Ethnicity was the only demographic variable to show dif-
ferential associations by fear indicator, with higher worry
in non-White groups but no differences in the other in-
dicators. As expected, general anxiety was associated
with all three indicators, although the moderate size of
the correlations is consistent with cancer fear being dis-
tinct from general anxiety. Controlling for general anx-
iety did not materially change the associations between
the sociodemographic predictors and the cancer fear
indicators.The endorsement rate for having cancer as greatest
health fear (59%) in this UK sample was similar to previ-
ous population surveys conducted in the US, UK, and
France, which have found rates of between 35% and 62%
[3,4,36]. Similar to findings in a French survey [4], more
women than men in our study expressed having cancer
as greatest health fear. The rate of cancer worry (25%)
was also similar to previous studies. General cancer
worry was reported in a quarter of UK adults [37], while
studies about specific types of cancer showed worry
about colorectal cancer in 13% to 23% of community-
based samples in the US and UK [34,38,39], and worry
about lung cancer in about 22% in the US [38]. Worry
about breast cancer tends to be higher; around a third of
women in the US, UK and Norway reported frequent or
considerable breast cancer worry [40-42]. This could be
due to the emblematic nature of breast cancer [43], but
also to the generally higher rates of cancer worry in
women. Similar to US based studies [17,18], we found
that rates of cancer worry tended to be higher in women
and people with lower education. Ethnic differences in
cancer worry are more difficult to compare across coun-
tries, because of the different ethnic minority groups.
Overall, comparing our findings with the results of pre-
vious studies suggests that gender and education differ-
ences in cancer fear may be fairly consistent across
Western countries.
The modest inter-correlation between the cancer fear
indicators, and the fact that the number of people who
identified cancer as their greatest health fear or experi-
enced discomfort thinking about cancer was twice the
number of people who experienced cancer worry, sug-
gests that the items used in the current study reflect
different aspects of the ‘cancer fear’ construct. This sup-
ports suggestions made by other authors that there
could be distinct cognitive and affective components of
what is often referred to as ‘cancer worry’ [8], and that
these components may need to be distinguished to
understand the role of cancer fear in cancer-related be-
haviours [7,8]. Cancer worry has been associated with
higher rates of cancer screening in some studies [7,44],
although this effect has not been entirely consistent (e.g.
[20,21]). But cancer fear may also promote avoidance of
the fear stimulus, and has indeed sometimes been men-
tioned as a barrier to screening [45] and shown to
impede cancer screening uptake [39,42]. The present
findings support observations made by other authors
that the variation in measurement strategies in studies
of cancer fear may have hampered our understanding of
its behavioural effects, and that a better understanding
of the construct is needed, including an exploration of
whether or not it is a multi-dimensional construct [7,8].
Although the components included in the current study
may not be the only relevant ones, our findings give
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different components of cancer fear could contribute to un-
derstanding of the concept. Further research is needed to
determine whether the behavioural effects – for example
on screening uptake - also vary by the specific cancer fear
component, what additional fear components need to be
distinguished, and how all of them could be measured
more accurately. Understanding the effects of different fear
components may also have implications for the evaluation
of public health interventions, which may need to include
multiple indicators of fear to accurately assess their effects
[for an example of a public health intervention evaluation
using multiple fear indicators, see [35]].
The moderate inter-correlations and differential en-
dorsement rates of the three items used in the present
study may also suggest a mechanism of protection
against worry. High fear states seldom persist unregu-
lated [7], and people who are uncomfortable when
thinking about cancer may deploy strategies to reduce
their daily worry about cancer. This would be consistent
with other common fears, where discussion of the fear
object can cause distress but emotional reactions do not
necessarily intrude in daily life; as distinct from true can-
cerophobia [46]. That said, a quarter of the population
worrying a lot about cancer, and more than half of the
population experiencing discomfort about it might be
seen as important issues for quality of life; and public
health authorities may be rightly cautious about magni-
fying cancer fears. However, given that cancer rates are
rising, and that there may be a motivating effect of can-
cer worry on screening uptake, three-quarters of the
population not worrying about cancer may also be con-
sidered a problem. The difficulty of identifying the ‘right’
level of fear for potentially modifiable risks is a general
problem in modern societies, and research is needed to
get a better understanding of the balance.
The impact of cancer fear on national healthcare
systems may be considerable. High cancer worry may
motivate more frequent consultations with healthcare
professionals to obtain reassurance [47-49]. Alternatively,
for individuals who cope using denial or avoidance, discom-
fort thinking or talking about cancer could lead to delay in
help-seeking for potential cancer symptoms [9,50,51] and
interfere with cancer screening uptake [40,52,53]. It could
also affect the success of public education on cancer. Miles
et al. [10] showed that people with higher levels of cancer
fear were more likely to avoid cancer information, including
information on the benefits of early detection, thus poten-
tially perpetuating negative beliefs about the scope to re-
duce cancer risk.
Previous research in an undergraduate sample found
moderate correlations between three indicators of cancer
fear and dispositional worry, suggesting that cancer fear
may be partly due to, but is also distinct from, generalanxiety [12]. A study of prostate cancer worry also found
only moderate correlations with trait anxiety [15]. The
results of the present study are important because they
indicate a similar pattern for general cancer fear in a
community sample at an age when the threat of cancer
is more relevant.
This study has several limitations. First, it was part of lar-
ger study that was not designed primarily to investigate
cancer fear, and so the selection of predictor variables may
not have been optimal. Nonetheless, the large sample size
was an advantage. Additional predictors could be consid-
ered in future studies, including personal or family history
of cancer and perceived personal risk. Participants were
aware that it was a survey about cancer and non-
responders may have been even more afraid of cancer than
responders. A larger proportion of our sample (63%) than
the national average of those born between 1936 and 1945
(45%; [54]) reported not having any educational qualifica-
tions, although this is unlikely to have influenced the asso-
ciations with cancer fear that were found in this study. The
large proportion of participants without educational qualifi-
cations may be due to the location of the General Practices
through which they were recruited, which were in more de-
prived areas of the country. Consistent with the proportion
of ethnic minorities in the older British population [55], the
majority (96%) of respondents in our sample were from a
White background, which limited the power of the study to
detect ethnic differences and made it difficult to interpret
our findings about the influence of ethnicity on cancer fear.
In addition, some evidence suggests that cancer fear is gen-
erally lower in those who are older [8], but investigation of
age effects was restricted by the narrow age-range of the
sample. Lastly, the three components of cancer fear were
each measured with single items to reduce participant bur-
den in the main study. There are validity problems associ-
ated with single item measures including limited reliability
and a limit on the maximum size of any associations,
although the effects are offset to some extent by the large
sample size.Conclusions
Cancer’s highly feared status was endorsed by the major-
ity of a large community sample of 55–64 year-olds, and
this was associated both with discomfort in thinking
about cancer and frequent worry. Women and people
with less education or from ethnic minority backgrounds
are disproportionately affected, independent of health
status and general anxiety. Because cancer fear is an un-
pleasant emotion, as well as potentially influencing
cancer-protective behaviours, it is important to gain a
better understanding of its origins and consequences,
and find ways to minimise its impact on quality of life
without undermining participation in cancer prevention.
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